Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score

Immunotherapy with immune checkpoint blockers (ICB) represents a valid therapeutic option in older patients for several solid cancer types. However, most of the data concerning efficacy and adverse events of ICB available are derived from younger and fitter patients. Reliable biomarkers are needed t...

Full description

Bibliographic Details
Main Authors: Monica Pierro, Capucine Baldini, Edouard Auclin, Hélène Vincent, Andreea Varga, Patricia Martin Romano, Perrine Vuagnat, Benjamin Besse, David Planchard, Antoine Hollebecque, Stéphane Champiat, Aurélien Marabelle, Jean-Marie Michot, Christophe Massard, Laura Mezquita
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/20/5078